In summary, our work argues that Notch signaling provides a constant drive on expression of sGC in arterial smooth muscle and that this is perturbed by hypertension via reduction of the transcriptional coactivators MAML2 and FRYL. The gene discussed is SGCB; the disease is Hypertension.